Bristol Myers Squibb is a global biopharmaceutical company committed to discovering, developing and delivering innovative medicines to patients with serious diseases.

Bristol-Myers Squibb Company is an American multinational pharmaceutical company headquartered in Princeton, New Jersey. [1] .

The resources on this page are offered by Bristol Myers Squibb to assist U.S. healthcare professionals in caring for patients and conducting research with BMS medicines.

From the scientists behind the microscope to the analysts behind the data, everyone at BMS is working to make an impact. And while our work transforms the lives of patients, it also transforms the lives …

Our mission is to enhance, to the fullest extent possible, the social, emotional, intellectual and physical development of our students. We offer a strong academic and special area program, guided by …

Use our Study Finder to help identify new or currently recruiting Bristol Myers Squibb sponsored studies that are being conducted. Submit your question to our team of medical professionals. Bristol Myers …

Dec 5, 2025 · With FDA approval to treat marginal zone lymphoma, BMS’s Breyanzi has become the first CAR-T therapy in the indication.

Dec 3, 2025 · Analysts had noted “unease” from investors regarding the state of the Phase III ADEPT-2 trial, with BMS at one point telling Leerink Partners that the reopening of enrollment would be a …

Dec 5, 2025 · Bristol Myers Squibb has taken CAR-T therapy into new territory, after getting FDA approval for Breyanzi in marginal zone lymphoma.

Learn more about Bristol Myers Squibb, a global biopharma company dedicated to discover, develop and deliver innovative medicines to patients with serious diseases.